| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 44 | 2025 | 622 | 9.790 |
Why?
|
| Genetic Diseases, Inborn | 13 | 2025 | 458 | 3.450 |
Why?
|
| Genetic Testing | 15 | 2025 | 1054 | 3.360 |
Why?
|
| Pregnancy | 87 | 2025 | 7327 | 3.020 |
Why?
|
| Genetic Counseling | 13 | 2025 | 236 | 2.780 |
Why?
|
| Amniocentesis | 7 | 2024 | 75 | 2.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2025 | 559 | 2.300 |
Why?
|
| Chromosome Disorders | 11 | 2019 | 315 | 1.960 |
Why?
|
| Oocytes | 6 | 2025 | 278 | 1.890 |
Why?
|
| Hydatidiform Mole | 9 | 2018 | 18 | 1.790 |
Why?
|
| DNA Methylation | 12 | 2025 | 1022 | 1.770 |
Why?
|
| Cell-Free Nucleic Acids | 4 | 2023 | 51 | 1.670 |
Why?
|
| Exome | 5 | 2022 | 1061 | 1.610 |
Why?
|
| Trophoblasts | 9 | 2023 | 113 | 1.510 |
Why?
|
| Genomic Imprinting | 6 | 2021 | 124 | 1.460 |
Why?
|
| X Chromosome | 13 | 2023 | 333 | 1.450 |
Why?
|
| Embryonic Development | 5 | 2025 | 210 | 1.440 |
Why?
|
| Fetus | 14 | 2025 | 577 | 1.440 |
Why?
|
| Female | 118 | 2025 | 67493 | 1.430 |
Why?
|
| Chorionic Villi Sampling | 6 | 2019 | 45 | 1.370 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2022 | 996 | 1.320 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 222 | 1.290 |
Why?
|
| Genomics | 4 | 2024 | 1555 | 1.290 |
Why?
|
| Rett Syndrome | 11 | 2006 | 291 | 1.250 |
Why?
|
| Fertilization in Vitro | 2 | 2020 | 151 | 1.200 |
Why?
|
| Stillbirth | 3 | 2025 | 95 | 1.150 |
Why?
|
| Genetic Carrier Screening | 2 | 2019 | 67 | 1.150 |
Why?
|
| Pregnancy Complications | 6 | 2022 | 532 | 1.120 |
Why?
|
| Pregnancy Trimester, First | 6 | 2022 | 119 | 1.120 |
Why?
|
| Incidental Findings | 3 | 2020 | 119 | 1.120 |
Why?
|
| Uterine Neoplasms | 6 | 2013 | 100 | 1.090 |
Why?
|
| Mutation | 17 | 2022 | 5908 | 1.080 |
Why?
|
| Transcriptome | 2 | 2025 | 1051 | 1.070 |
Why?
|
| Congenital Abnormalities | 4 | 2025 | 299 | 1.060 |
Why?
|
| Zygote | 3 | 2025 | 29 | 1.050 |
Why?
|
| Humans | 130 | 2025 | 124973 | 1.030 |
Why?
|
| Nervous System Malformations | 3 | 2022 | 119 | 1.000 |
Why?
|
| Gestational Age | 6 | 2024 | 1202 | 0.990 |
Why?
|
| Focal Dermal Hypoplasia | 6 | 2014 | 17 | 0.970 |
Why?
|
| Proteins | 5 | 2023 | 1013 | 0.970 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2016 | 558 | 0.970 |
Why?
|
| Chromosome Aberrations | 10 | 2018 | 573 | 0.960 |
Why?
|
| DNA Copy Number Variations | 10 | 2019 | 996 | 0.950 |
Why?
|
| Fetal Death | 2 | 2025 | 118 | 0.950 |
Why?
|
| Aneuploidy | 8 | 2024 | 138 | 0.920 |
Why?
|
| Amniotic Fluid | 8 | 2015 | 151 | 0.900 |
Why?
|
| Prenatal Care | 6 | 2023 | 345 | 0.840 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2023 | 22 | 0.810 |
Why?
|
| Phenotype | 17 | 2024 | 4296 | 0.810 |
Why?
|
| Turner Syndrome | 2 | 2023 | 45 | 0.800 |
Why?
|
| Pregnancy Proteins | 1 | 2023 | 14 | 0.790 |
Why?
|
| Down Syndrome | 4 | 2023 | 199 | 0.790 |
Why?
|
| Microarray Analysis | 8 | 2023 | 224 | 0.790 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 159 | 0.780 |
Why?
|
| Histone Demethylases | 1 | 2023 | 37 | 0.780 |
Why?
|
| Karyopherins | 1 | 2023 | 33 | 0.780 |
Why?
|
| Sequence Analysis, DNA | 9 | 2020 | 1719 | 0.770 |
Why?
|
| Fetal Diseases | 7 | 2015 | 455 | 0.760 |
Why?
|
| Preimplantation Diagnosis | 2 | 2020 | 26 | 0.730 |
Why?
|
| Metabolomics | 1 | 2025 | 448 | 0.730 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 76 | 0.730 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 1000 | 0.710 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2021 | 16 | 0.700 |
Why?
|
| Sex Chromosome Aberrations | 4 | 2017 | 62 | 0.690 |
Why?
|
| Databases, Genetic | 2 | 2024 | 481 | 0.690 |
Why?
|
| Epigenesis, Genetic | 4 | 2025 | 702 | 0.670 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2011 | 199 | 0.670 |
Why?
|
| Genetic Linkage | 8 | 2010 | 462 | 0.660 |
Why?
|
| Gene Deletion | 5 | 2018 | 763 | 0.660 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2024 | 891 | 0.660 |
Why?
|
| Germ Cells | 1 | 2021 | 195 | 0.650 |
Why?
|
| Genes, Lethal | 5 | 2024 | 75 | 0.590 |
Why?
|
| Cellular Reprogramming | 2 | 2017 | 107 | 0.580 |
Why?
|
| Karyotyping | 5 | 2024 | 313 | 0.580 |
Why?
|
| Maternal Exposure | 1 | 2019 | 145 | 0.570 |
Why?
|
| Diet, Protein-Restricted | 2 | 2017 | 80 | 0.560 |
Why?
|
| Preconception Care | 1 | 2018 | 15 | 0.560 |
Why?
|
| Reproductive Medicine | 1 | 2018 | 20 | 0.550 |
Why?
|
| Mice | 19 | 2025 | 17411 | 0.550 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 229 | 0.530 |
Why?
|
| White Matter | 1 | 2019 | 206 | 0.530 |
Why?
|
| Rh-Hr Blood-Group System | 4 | 1999 | 12 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2025 | 962 | 0.510 |
Why?
|
| Microphthalmos | 3 | 2002 | 55 | 0.510 |
Why?
|
| Physicians | 1 | 2023 | 615 | 0.510 |
Why?
|
| Gene Dosage | 7 | 2012 | 440 | 0.510 |
Why?
|
| Precision Medicine | 1 | 2019 | 342 | 0.500 |
Why?
|
| Retinal Diseases | 3 | 2012 | 164 | 0.500 |
Why?
|
| Patient Participation | 1 | 2019 | 228 | 0.500 |
Why?
|
| Cerebellum | 2 | 2019 | 414 | 0.490 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 445 | 0.490 |
Why?
|
| DNA | 11 | 2021 | 1422 | 0.490 |
Why?
|
| DNA Mutational Analysis | 13 | 2014 | 779 | 0.480 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 189 | 0.480 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 1680 | 0.480 |
Why?
|
| Single-Cell Analysis | 6 | 2021 | 314 | 0.480 |
Why?
|
| Pregnancy Outcome | 4 | 2024 | 615 | 0.470 |
Why?
|
| Genes | 3 | 2014 | 305 | 0.460 |
Why?
|
| Membrane Proteins | 4 | 2012 | 1529 | 0.450 |
Why?
|
| Retrospective Studies | 14 | 2025 | 16569 | 0.450 |
Why?
|
| Fertility | 1 | 2017 | 250 | 0.450 |
Why?
|
| Stress, Psychological | 1 | 2019 | 544 | 0.440 |
Why?
|
| Anxiety | 2 | 2022 | 962 | 0.440 |
Why?
|
| Supreme Court Decisions | 1 | 2014 | 16 | 0.440 |
Why?
|
| Patents as Topic | 1 | 2014 | 19 | 0.440 |
Why?
|
| Animals | 25 | 2025 | 32914 | 0.440 |
Why?
|
| Lipoma | 1 | 2014 | 24 | 0.430 |
Why?
|
| Nevus | 1 | 2014 | 35 | 0.430 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 305 | 0.430 |
Why?
|
| Polymerase Chain Reaction | 9 | 2010 | 1485 | 0.430 |
Why?
|
| Syndrome | 10 | 2009 | 1120 | 0.430 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2014 | 62 | 0.420 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1073 | 0.420 |
Why?
|
| Lyases | 3 | 2002 | 12 | 0.420 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 16 | 0.410 |
Why?
|
| Sleep | 1 | 2017 | 358 | 0.410 |
Why?
|
| Adult | 30 | 2025 | 30051 | 0.410 |
Why?
|
| Skin Abnormalities | 3 | 2002 | 35 | 0.410 |
Why?
|
| Placenta | 5 | 2022 | 509 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1213 | 0.410 |
Why?
|
| Patient Rights | 1 | 2013 | 50 | 0.400 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2009 | 79 | 0.400 |
Why?
|
| Developmental Disabilities | 2 | 2009 | 715 | 0.400 |
Why?
|
| GTPase-Activating Proteins | 2 | 2005 | 85 | 0.400 |
Why?
|
| Mosaicism | 5 | 2022 | 232 | 0.400 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2017 | 752 | 0.400 |
Why?
|
| Vascular Malformations | 1 | 2014 | 107 | 0.390 |
Why?
|
| Exons | 6 | 2009 | 748 | 0.390 |
Why?
|
| Infant, Newborn | 15 | 2023 | 8324 | 0.390 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 323 | 0.380 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1748 | 0.380 |
Why?
|
| Energy Metabolism | 1 | 2017 | 758 | 0.370 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2006 | 308 | 0.360 |
Why?
|
| Blastocyst | 4 | 2020 | 72 | 0.350 |
Why?
|
| Base Sequence | 11 | 2013 | 2761 | 0.340 |
Why?
|
| Fetal Blood | 3 | 1996 | 165 | 0.330 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2010 | 33 | 0.330 |
Why?
|
| Microtubule Proteins | 2 | 2001 | 27 | 0.320 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 263 | 0.320 |
Why?
|
| Male | 34 | 2025 | 61670 | 0.320 |
Why?
|
| Abortion, Habitual | 2 | 2014 | 17 | 0.320 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 436 | 0.320 |
Why?
|
| Genes, Dominant | 4 | 2002 | 240 | 0.310 |
Why?
|
| Genetic Markers | 3 | 2019 | 592 | 0.310 |
Why?
|
| Abnormalities, Multiple | 6 | 2019 | 968 | 0.310 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 4391 | 0.310 |
Why?
|
| Genome, Human | 4 | 2015 | 1256 | 0.310 |
Why?
|
| DNA-Binding Proteins | 7 | 2003 | 1868 | 0.300 |
Why?
|
| Chromosomes, Human, X | 3 | 2017 | 155 | 0.300 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2007 | 44 | 0.300 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 62 | 0.300 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2024 | 167 | 0.290 |
Why?
|
| Transcription Factors | 5 | 2014 | 2322 | 0.290 |
Why?
|
| Pigmentation Disorders | 3 | 2010 | 22 | 0.290 |
Why?
|
| Embryonic Stem Cells | 2 | 2023 | 160 | 0.280 |
Why?
|
| Bone Diseases, Developmental | 3 | 2010 | 60 | 0.280 |
Why?
|
| Dosage Compensation, Genetic | 5 | 2001 | 59 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2005 | 59 | 0.280 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2009 | 60 | 0.280 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 3588 | 0.280 |
Why?
|
| Referral and Consultation | 2 | 2025 | 550 | 0.270 |
Why?
|
| Nuclear Proteins | 4 | 2003 | 1203 | 0.270 |
Why?
|
| Inheritance Patterns | 4 | 2018 | 128 | 0.270 |
Why?
|
| Lymphocytes | 3 | 2012 | 354 | 0.270 |
Why?
|
| Obstetrics | 1 | 2010 | 241 | 0.260 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 61 | 0.260 |
Why?
|
| Repressor Proteins | 5 | 2003 | 759 | 0.260 |
Why?
|
| Wnt Proteins | 1 | 2007 | 200 | 0.250 |
Why?
|
| Sequence Deletion | 2 | 2010 | 510 | 0.250 |
Why?
|
| Mice, Knockout | 4 | 2025 | 3661 | 0.240 |
Why?
|
| Health Surveys | 1 | 2007 | 245 | 0.240 |
Why?
|
| Dental Enamel Proteins | 1 | 2005 | 2 | 0.240 |
Why?
|
| Facial Bones | 1 | 2005 | 27 | 0.240 |
Why?
|
| Lymphangioma, Cystic | 2 | 2023 | 15 | 0.240 |
Why?
|
| Choroid Diseases | 1 | 2005 | 17 | 0.240 |
Why?
|
| Dental Enamel | 1 | 2005 | 19 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2019 | 492 | 0.230 |
Why?
|
| Genes, Recessive | 1 | 2006 | 185 | 0.230 |
Why?
|
| Pedigree | 10 | 2019 | 1652 | 0.230 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 2160 | 0.230 |
Why?
|
| Hydrops Fetalis | 2 | 2023 | 85 | 0.230 |
Why?
|
| Mass Screening | 2 | 2022 | 791 | 0.220 |
Why?
|
| Autopsy | 1 | 2025 | 112 | 0.220 |
Why?
|
| Contractile Proteins | 1 | 2004 | 16 | 0.210 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2017 | 51 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2014 | 2878 | 0.210 |
Why?
|
| Inclusion Bodies | 1 | 2004 | 36 | 0.210 |
Why?
|
| Gene Duplication | 3 | 2018 | 368 | 0.210 |
Why?
|
| HLA-G Antigens | 1 | 2023 | 13 | 0.210 |
Why?
|
| Spasms, Infantile | 1 | 2005 | 174 | 0.210 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2023 | 35 | 0.210 |
Why?
|
| Activins | 1 | 2023 | 72 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2023 | 51 | 0.200 |
Why?
|
| Maternal Inheritance | 1 | 2023 | 14 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2005 | 2301 | 0.200 |
Why?
|
| Genotype | 6 | 2018 | 2586 | 0.200 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 26 | 0.200 |
Why?
|
| Cell Differentiation | 3 | 2023 | 1838 | 0.190 |
Why?
|
| Cell Separation | 2 | 2020 | 218 | 0.190 |
Why?
|
| Ribosomal Proteins | 1 | 2023 | 71 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 113 | 0.190 |
Why?
|
| Basal Ganglia Diseases | 1 | 2002 | 24 | 0.180 |
Why?
|
| Informed Consent | 2 | 2015 | 336 | 0.180 |
Why?
|
| Blood Grouping and Crossmatching | 2 | 1999 | 14 | 0.180 |
Why?
|
| Young Adult | 7 | 2019 | 9535 | 0.180 |
Why?
|
| Ligases | 1 | 2001 | 36 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 4460 | 0.180 |
Why?
|
| Polydactyly | 1 | 2001 | 18 | 0.180 |
Why?
|
| Acyltransferases | 3 | 2012 | 44 | 0.180 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 148 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 20 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2014 | 2703 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2004 | 282 | 0.170 |
Why?
|
| Urogenital Abnormalities | 1 | 2023 | 160 | 0.170 |
Why?
|
| Superovulation | 1 | 2020 | 12 | 0.170 |
Why?
|
| Genetic Variation | 4 | 2015 | 1509 | 0.170 |
Why?
|
| Astrocytes | 1 | 2004 | 260 | 0.170 |
Why?
|
| Chromatin | 4 | 2013 | 489 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 443 | 0.170 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 23 | 0.170 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 54 | 0.170 |
Why?
|
| Point Mutation | 4 | 2007 | 339 | 0.170 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2019 | 18 | 0.170 |
Why?
|
| Rh Isoimmunization | 2 | 1999 | 26 | 0.170 |
Why?
|
| Embryo Transfer | 1 | 2020 | 46 | 0.170 |
Why?
|
| Adolescent | 9 | 2017 | 19921 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2014 | 4413 | 0.160 |
Why?
|
| Hydrocephalus | 1 | 2022 | 276 | 0.160 |
Why?
|
| Meningomyelocele | 1 | 2023 | 249 | 0.160 |
Why?
|
| Mullerian Ducts | 2 | 2023 | 45 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2001 | 318 | 0.160 |
Why?
|
| Cell Shape | 2 | 2017 | 67 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 343 | 0.160 |
Why?
|
| Mothers | 1 | 2023 | 363 | 0.160 |
Why?
|
| Indomethacin | 3 | 1994 | 81 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 1234 | 0.150 |
Why?
|
| Erythroblastosis, Fetal | 2 | 1999 | 27 | 0.150 |
Why?
|
| Maternal Behavior | 1 | 2019 | 68 | 0.150 |
Why?
|
| RNA Helicases | 1 | 2019 | 68 | 0.150 |
Why?
|
| Introns | 3 | 2012 | 280 | 0.150 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2016 | 64 | 0.150 |
Why?
|
| CpG Islands | 2 | 2013 | 326 | 0.140 |
Why?
|
| Chromosome Mapping | 6 | 2005 | 1070 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 137 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 1998 | 108 | 0.140 |
Why?
|
| Uterine Diseases | 1 | 1998 | 22 | 0.140 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 317 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 242 | 0.140 |
Why?
|
| Mutation, Missense | 3 | 2019 | 877 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 3202 | 0.130 |
Why?
|
| Fertilization | 1 | 2017 | 42 | 0.130 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.130 |
Why?
|
| Liver | 2 | 2017 | 1734 | 0.130 |
Why?
|
| Genome | 1 | 2019 | 483 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2018 | 3389 | 0.130 |
Why?
|
| Androgens | 1 | 2018 | 266 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 1486 | 0.120 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 106 | 0.120 |
Why?
|
| Infant | 9 | 2019 | 12733 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 10275 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2020 | 1638 | 0.120 |
Why?
|
| Hypothalamus | 1 | 2017 | 187 | 0.120 |
Why?
|
| Virus Diseases | 1 | 1998 | 265 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 648 | 0.110 |
Why?
|
| Biomarkers | 2 | 2022 | 3115 | 0.110 |
Why?
|
| Diet | 1 | 2002 | 1096 | 0.110 |
Why?
|
| Child | 10 | 2014 | 25038 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2023 | 14341 | 0.110 |
Why?
|
| Confidentiality | 1 | 2015 | 103 | 0.110 |
Why?
|
| Reproductive Health Services | 1 | 2014 | 19 | 0.110 |
Why?
|
| Hippocampus | 1 | 2019 | 770 | 0.110 |
Why?
|
| Protein Binding | 2 | 2017 | 1653 | 0.110 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1994 | 7 | 0.110 |
Why?
|
| Antigens, Human Platelet | 1 | 1994 | 6 | 0.110 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 1994 | 49 | 0.110 |
Why?
|
| Obstetric Labor, Premature | 2 | 1993 | 81 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 729 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 77 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2017 | 472 | 0.100 |
Why?
|
| Cell Line | 3 | 2016 | 2545 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 522 | 0.100 |
Why?
|
| Infertility, Female | 1 | 2014 | 144 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2013 | 322 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1993 | 92 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 198 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1998 | 464 | 0.100 |
Why?
|
| Ductus Arteriosus | 1 | 1993 | 60 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 2013 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 208 | 0.100 |
Why?
|
| Pupil Disorders | 1 | 2012 | 12 | 0.090 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 367 | 0.090 |
Why?
|
| Wnt3A Protein | 1 | 2012 | 11 | 0.090 |
Why?
|
| Breeding | 1 | 2012 | 19 | 0.090 |
Why?
|
| Aicardi Syndrome | 1 | 2012 | 15 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 277 | 0.090 |
Why?
|
| Chimera | 1 | 2012 | 80 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1994 | 366 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 463 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 129 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 51 | 0.090 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 101 | 0.090 |
Why?
|
| Metagenomics | 1 | 2012 | 106 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 222 | 0.090 |
Why?
|
| Mediator Complex | 1 | 2011 | 56 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2012 | 165 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 138 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2006 | 2539 | 0.090 |
Why?
|
| Twins | 1 | 1991 | 69 | 0.080 |
Why?
|
| Pregnancy, Multiple | 1 | 1991 | 43 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 814 | 0.080 |
Why?
|
| Vagina | 1 | 2012 | 198 | 0.080 |
Why?
|
| Femur Head Necrosis | 1 | 1990 | 7 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 170 | 0.080 |
Why?
|
| Cardiotocography | 1 | 2010 | 20 | 0.080 |
Why?
|
| Hyperammonemia | 1 | 2010 | 59 | 0.080 |
Why?
|
| Sex Chromosome Disorders | 1 | 2009 | 9 | 0.080 |
Why?
|
| Family Health | 3 | 2007 | 247 | 0.080 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2009 | 19 | 0.080 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 37 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 77 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 2308 | 0.070 |
Why?
|
| Prognosis | 1 | 2018 | 4629 | 0.070 |
Why?
|
| Egypt | 1 | 2007 | 26 | 0.070 |
Why?
|
| Heterozygote | 1 | 2010 | 690 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 650 | 0.070 |
Why?
|
| Epididymis | 1 | 1988 | 60 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2001 | 347 | 0.070 |
Why?
|
| Varicocele | 1 | 1988 | 61 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2005 | 229 | 0.060 |
Why?
|
| DNA Primers | 3 | 1998 | 601 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 217 | 0.060 |
Why?
|
| Foot Deformities, Congenital | 2 | 2010 | 16 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3254 | 0.060 |
Why?
|
| Disease Management | 1 | 2010 | 528 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2006 | 83 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 297 | 0.060 |
Why?
|
| Clone Cells | 1 | 2006 | 164 | 0.060 |
Why?
|
| Mutant Proteins | 1 | 2006 | 111 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 394 | 0.060 |
Why?
|
| Amelogenesis Imperfecta | 1 | 2005 | 1 | 0.060 |
Why?
|
| Amelogenin | 1 | 2005 | 3 | 0.060 |
Why?
|
| Tooth | 1 | 2005 | 15 | 0.060 |
Why?
|
| Hand Deformities, Congenital | 2 | 2010 | 94 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 130 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 124 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2003 | 234 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 2 | 1998 | 116 | 0.060 |
Why?
|
| Infertility, Male | 1 | 1988 | 284 | 0.060 |
Why?
|
| Genes, Essential | 1 | 2024 | 42 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 1203 | 0.050 |
Why?
|
| Filamins | 1 | 2004 | 27 | 0.050 |
Why?
|
| Gene Library | 1 | 2004 | 208 | 0.050 |
Why?
|
| Chorionic Villi | 1 | 2003 | 22 | 0.050 |
Why?
|
| Texas | 1 | 2012 | 3509 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2004 | 101 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2007 | 1453 | 0.050 |
Why?
|
| Totipotent Stem Cells | 1 | 2002 | 2 | 0.050 |
Why?
|
| Holoenzymes | 1 | 2002 | 14 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 55 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 250 | 0.050 |
Why?
|
| Human Development | 1 | 2002 | 6 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2016 | 4852 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 785 | 0.050 |
Why?
|
| Seizures | 1 | 2007 | 854 | 0.050 |
Why?
|
| Family | 2 | 2018 | 574 | 0.050 |
Why?
|
| Attitude | 1 | 2022 | 108 | 0.040 |
Why?
|
| Recurrence | 1 | 2005 | 1387 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 158 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 328 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 207 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2001 | 34 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1999 | 432 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 359 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2001 | 111 | 0.040 |
Why?
|
| Attention | 1 | 2022 | 193 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2001 | 92 | 0.040 |
Why?
|
| Homozygote | 1 | 2022 | 541 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2091 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2001 | 158 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 306 | 0.040 |
Why?
|
| Fibroma | 1 | 2000 | 28 | 0.040 |
Why?
|
| Age Factors | 1 | 2007 | 2749 | 0.040 |
Why?
|
| Cell Survival | 1 | 2002 | 820 | 0.040 |
Why?
|
| Calcinosis | 1 | 2002 | 182 | 0.040 |
Why?
|
| Counseling | 1 | 2022 | 230 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2846 | 0.040 |
Why?
|
| Folic Acid | 1 | 2002 | 277 | 0.040 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 6 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 607 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 531 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 87 | 0.040 |
Why?
|
| Achondroplasia | 1 | 2019 | 24 | 0.040 |
Why?
|
| United States | 1 | 2014 | 11095 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 30 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2019 | 43 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 43 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 113 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 1998 | 54 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 135 | 0.040 |
Why?
|
| Skin | 1 | 2001 | 510 | 0.040 |
Why?
|
| Chromosomes | 1 | 2018 | 131 | 0.040 |
Why?
|
| RNA Virus Infections | 1 | 1998 | 6 | 0.040 |
Why?
|
| Radiography | 2 | 2010 | 744 | 0.040 |
Why?
|
| Neural Tube Defects | 1 | 2002 | 362 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 412 | 0.040 |
Why?
|
| DNA Virus Infections | 1 | 1998 | 22 | 0.030 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2017 | 4 | 0.030 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2017 | 15 | 0.030 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2017 | 19 | 0.030 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2017 | 15 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2017 | 19 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1998 | 393 | 0.030 |
Why?
|
| Species Specificity | 1 | 1998 | 518 | 0.030 |
Why?
|
| Mammals | 1 | 2018 | 249 | 0.030 |
Why?
|
| Trisomy | 1 | 2017 | 108 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 2017 | 69 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1904 | 0.030 |
Why?
|
| Brain | 1 | 2008 | 3020 | 0.030 |
Why?
|
| Contraindications | 2 | 1994 | 74 | 0.030 |
Why?
|
| Prader-Willi Syndrome | 1 | 2017 | 67 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 2016 | 42 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 292 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2004 | 1051 | 0.030 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 167 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1998 | 294 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 651 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1811 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 41 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 146 | 0.030 |
Why?
|
| Fathers | 1 | 1996 | 70 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 3555 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 802 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 642 | 0.030 |
Why?
|
| Blastomeres | 1 | 1995 | 6 | 0.030 |
Why?
|
| Israel | 1 | 2015 | 48 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1995 | 27 | 0.030 |
Why?
|
| Parents | 1 | 2022 | 1073 | 0.030 |
Why?
|
| Drosophila | 1 | 1999 | 780 | 0.030 |
Why?
|
| Fetal Monitoring | 2 | 1994 | 58 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 1995 | 121 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 1994 | 54 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 59 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 1994 | 27 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 1597 | 0.030 |
Why?
|
| Dystrophin | 1 | 1994 | 39 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1994 | 59 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 281 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 779 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 716 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 747 | 0.030 |
Why?
|
| Diastole | 1 | 1993 | 168 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 3877 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1993 | 220 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 2542 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 1993 | 430 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 86 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1993 | 762 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 347 | 0.020 |
Why?
|
| Williams Syndrome | 1 | 2012 | 41 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 63 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2003 | 1013 | 0.020 |
Why?
|
| Ultrasonography | 2 | 1993 | 947 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 153 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1995 | 390 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2003 | 363 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 481 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1990 | 36 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1374 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 89 | 0.020 |
Why?
|
| Lactation | 1 | 2011 | 193 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2012 | 219 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 137 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1995 | 420 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2011 | 6133 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 129 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 5042 | 0.020 |
Why?
|
| Algorithms | 1 | 1996 | 1620 | 0.020 |
Why?
|
| Lod Score | 2 | 2000 | 125 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 62 | 0.020 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Central Nervous System Cysts | 1 | 2008 | 11 | 0.020 |
Why?
|
| Polysomnography | 1 | 2010 | 150 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 621 | 0.020 |
Why?
|
| Malformations of Cortical Development | 1 | 2008 | 54 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 510 | 0.020 |
Why?
|
| Palpation | 1 | 1988 | 18 | 0.020 |
Why?
|
| Testicular Diseases | 1 | 1988 | 12 | 0.020 |
Why?
|
| Haplotypes | 2 | 2000 | 515 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 968 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2006 | 138 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1333 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 88 | 0.020 |
Why?
|
| Breast | 1 | 1988 | 209 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 686 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 960 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2004 | 16 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 48 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2004 | 175 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 125 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2004 | 90 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 13 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 133 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 55 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 67 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 111 | 0.010 |
Why?
|
| Placentation | 1 | 2003 | 58 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 142 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 454 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 452 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 721 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 194 | 0.010 |
Why?
|
| Lymphoma | 1 | 2004 | 307 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 659 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 735 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1589 | 0.010 |
Why?
|
| Histones | 1 | 2003 | 503 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 251 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 422 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1363 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1374 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 786 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 1184 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1988 | 2555 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 125 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1995 | 98 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 223 | 0.010 |
Why?
|
| Sex Determination Analysis | 1 | 1994 | 15 | 0.010 |
Why?
|
| Organ Size | 1 | 1995 | 435 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1994 | 52 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1904 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 5987 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1994 | 226 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 2921 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1988 | 7 | 0.000 |
Why?
|
| Thermography | 1 | 1988 | 11 | 0.000 |
Why?
|
| Lung | 1 | 1995 | 1506 | 0.000 |
Why?
|
| Mammography | 1 | 1988 | 125 | 0.000 |
Why?
|
| Physical Examination | 1 | 1988 | 159 | 0.000 |
Why?
|
| Middle Aged | 1 | 1988 | 27074 | 0.000 |
Why?
|